Baker Biotech Capital II (Z) (GP), LLC Insider Trading
Get free email notifications about insider trading for Baker Biotech Capital II (Z) (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital II (Z) (GP), LLC. Baker Biotech Capital II (Z) (GP), LLC is a 10% Owner in VIROPHARMA INC ($VPHM) and a 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and a Director in SEATTLE GENETICS INC /WA ($SGEN).
Address: 667 MADISON AVENUE NEW YORK 10021 NY
Companies in which Baker Biotech Capital II (Z) (GP), LLC is an Insider
Ardea Biosciences, Inc./DE
Trading Symbol: IBPIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital II (Z) (GP), LLC: 10% Owner
Holdings: 49,200 shares
Latest Transaction: Apr 14 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Trading Symbol: SGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital II (Z) (GP), LLC: Director
Holdings: 49,807 shares
Current Value: $3,027,768
Latest Transaction: May 06 2005
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VIROPHARMA INC
Trading Symbol: VPHMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital II (Z) (GP), LLC: 10% Owner
Holdings: 103,540 shares
Latest Transaction: Mar 01 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Baker Biotech Capital II (Z) (GP), LLC
Sentiment: All, IBPI, SGEN, VPHM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (Z) ( ... | 10% Owner | Sell | S | 20.41 | 5,169 | 105,504 | 103,540 | 108.7 K to 103.5 K (-4.75 %) |
Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (Z) ( ... | 10% Owner | Sell | S | 19.90 | 10,508 | 209,060 | 108,709 | 119.2 K to 108.7 K (-8.81 %) |
Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (Z) ( ... | 10% Owner | Sell | S | 21.81 | 30 | 654 | 119,217 | 119.2 K to 119.2 K (-0.03 %) |
Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (Z) ( ... | 10% Owner | Sell | S | 21.58 | 1,606 | 34,657 | 119,247 | 120.9 K to 119.2 K (-1.33 %) |
Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (Z) ( ... | 10% Owner | Sell | S | 21.72 | 7,165 | 155,654 | 120,853 | 128 K to 120.9 K (-5.60 %) |
Mar 01 2006 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (Z) ( ... | 10% Owner | Sell | S | 21.74 | 7,080 | 153,940 | 128,018 | 135.1 K to 128 K (-5.24 %) |
May 12 2005 | VPHM | VIROPHARMA INC | Baker Biotech Capital II (Z) ( ... | 10% Owner | Option Exercise | P | 2.50 | 19,000 | 47,500 | 315,000 |
View all Baker Biotech Capital II (Z) (GP), LLC insider transactions.